Results 1 to 10 of about 27,470 (164)

Optimal control dynamics of Gonorrhea in a structured population

Heliyon, 2023
Gonorrhea is a serious global health problem due to its high incidence, with approximately 82.4 million new cases in 2020. To evaluate the consequences of targeted dynamic control of gonorrhea infection transmission, a model for gonorrhea with optimal ...
, Gui-Quan Sun, Joshua Kiddy K Asamoah
exaly   +3 more sources

Adult gonorrhea, chlamydia and syphilis prevalence, incidence, treatment and syndromic case reporting in South Africa: Estimates using the Spectrum-STI model, 1990-2017 [PDF]

PLoS ONE, 2018
OBJECTIVES:To estimate trends in prevalence and incidence of syphilis, gonorrhea and chlamydia in adult men and women in South Africa. METHODS:The Spectrum-STI tool estimated trends in prevalence and incidence of active syphilis, gonorrhea and chlamydia,
Leigh Johnson, Melanie Taylor, Eline Korenromp   +2 more
exaly   +2 more sources

Mathematical analysis of a model for Chlamydia and Gonorrhea codynamics with optimal control

Results in Physics, 2021
A model for Chlamydia trachomatis (CT) and Gonorrhea codynamics, with optimal control analysis is studied and analyzed to assess the impact of targetted treatment for each of the diseases on their co-infections in a population.
Andrew Omame, Chibueze Onyenegecha
exaly   +3 more sources

Exploitation of Neisseria meningitidis Group B OMV Vaccines Against N. gonorrhoeae to Inform the Development and Deployment of Effective Gonorrhea Vaccines

Frontiers in Immunology, 2019
Have potential clues to an effective gonorrhea vaccine been lurking in international disease surveillance data for decades? While no clinically effective vaccines against gonorrhea have been developed we present direct and indirect evidence that a ...
Helen Petousis-Harris, Fiona Radcliff
exaly   +3 more sources

The Impact of Educational Intervention on Willingness to Enroll in a Clinical Trial of a Gonorrhea Vaccine

Vaccines, 2023
Globally, >80 million new gonorrhea infections occur annually. Here, we assessed barriers to and influences on participation in a gonorrhea clinical trial and the impact of educational intervention. The survey was fielded in the US in March 2022.
Michael Penlington, Uwe Nicolay, Ilaria Galgani   +2 more
doaj   +1 more source

EPIDEMIOLOGICAL TRENDS OF ANTIBIOTIC-RESISTANT NEISSERIA GONORRHEA IN THE EU/EEA/EUROPEAN REGION: A SYSTEMATIC REVIEW

Health Problems of Civilization, 2023
Neisseria gonorrhea is becoming more resistant to available antibiotic treatments. The growing antibiotic resistance of Neisseria gonorrhea in clinical isolates has been observed by different national surveillance systems around the globe and is ...
Gurkeerat Gill
doaj   +1 more source

Factors Influencing Temporary Sexual Behavior in Patients with Gonorrhea in STD Clinics [PDF]

SHS Web of Conferences, 2022
Objective: To explore risk factors influencing temporary sexual behavior among gonorrhea patients in STD clinics, and to adapt gonorrhea prevention and control strategies accordingly.
Wang Nan
doaj   +1 more source

Evaluating spatially adaptive guidelines for the treatment of gonorrhea to reduce the incidence of gonococcal infection and increase the effective lifespan of antibiotics.

PLoS Computational Biology, 2022
In the absence of point-of-care gonorrhea diagnostics that report antibiotic susceptibility, gonorrhea treatment is empiric and determined by standardized guidelines.
Reza Yaesoubi, Ted Cohen, Katherine Hsu, Thomas L Gift, Sancta B St Cyr, Joshua A Salomon, Yonatan H Grad   +6 more
doaj   +1 more source

Interruption time series analysis using autoregressive integrated moving average model: evaluating the impact of COVID-19 on the epidemic trend of gonorrhea in China

BMC Public Health, 2023
Background Interrupted time series (ITS) analysis is a growing method for assessing intervention impacts on diseases. However, it remains unstudied how the COVID-19 outbreak impacts gonorrhea.
Yanyan Li, Xingyan Liu, Xinxiao Li, Chenlu Xue, Bingjie Zhang, Yongbin Wang   +5 more
doaj   +1 more source

Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016

BMC Infectious Diseases, 2018
Background The European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP) performs annual sentinel surveillance of Neisseria gonorrhoeae susceptibility to therapeutically relevant antimicrobials across the European Union/European Economic Area (
Michaela J. Day, Gianfranco Spiteri, Susanne Jacobsson, Neil Woodford, Andrew J. Amato-Gauci, Michelle J. Cole, Magnus Unemo, Euro-GASP network   +7 more
doaj   +1 more source